Thoracoscopic Transthoracic Hepatectomy for Hepatocellular Carcinoma in Budd-Chiari Syndrome

Atsushi Takebe1, Masaya Nakano1, Katsuya Ami1

  • 1Department of Surgery, Kindai University Hospital, Osaka, Japan.

Insights

Budd-Chiari syndrome (BCS) patients with liver cancer (hepatocellular carcinoma, HCC) can be treated with thoracoscopic transthoracic hepatectomy (TTH). This minimally invasive surgery is a viable option for high-risk BCS patients.

Area of Science:

  • Hepatobiliary surgery
  • Interventional oncology
  • Vascular surgery

Background:

  • Budd-Chiari syndrome (BCS) is a rare condition characterized by hepatic venous outflow obstruction, leading to liver congestion and portal hypertension.
  • Hepatocellular carcinoma (HCC) incidence is notably higher in patients with BCS.
  • Management of HCC in BCS patients requires careful consideration of hemodynamic status and minimally invasive surgical options.

Observation:

  • An 88-year-old female patient with BCS presented with a hepatic tumor in liver segment 8.
  • Preoperative hemodynamic assessment using angiography was performed.
  • A thoracoscopic transthoracic hepatectomy (TTH) was chosen as the surgical approach.

Findings:

  • Thoracoscopic transthoracic hepatectomy (TTH) was successfully performed for HCC in a BCS patient.
  • The procedure was minimally invasive and guided by detailed hemodynamic evaluation.
  • This approach was feasible and effective in managing the complex case.

Implications:

  • Thoracoscopic transthoracic hepatectomy (TTH) offers a potential minimally invasive solution for HCC in high-risk patients, including those with BCS.
  • Hemodynamic assessment is crucial for selecting appropriate surgical strategies in BCS patients with HCC.
  • This case highlights the adaptability of advanced surgical techniques for challenging oncological conditions.

Related Concept Videos